Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-05 11:11 am Sale | 2025-05-30 | 13G | Regeneron Pharmaceuticals, Inc. REGN | JPMORGAN CHASE & CO JPM | 4,742,611 4.400% | -803,823 (-14.49%) | Filing History |
| 2025-04-22 12:01 pm Sale | 2025-03-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN | JPMORGAN CHASE & CO JPM | 5,546,434 5.100% | -1,673,002 (-23.17%) | Filing History |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 8,188,770 7.600% | -2,128,637 (-20.63%) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN | The Vanguard Group | 8,838,240 8.250% | 115,792 (+1.33%) | Filing History |
| 2024-02-09 6:19 pm Sale | 2024-02-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 5,194,729 4.800% | -1,121,090 (-17.75%) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 10,317,407 9.630% | -779,577 (-7.03%) | Filing History |
| 2024-01-25 4:59 pm Sale | 2023-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN | BlackRock Inc. BLK | 8,629,707 8.100% | -537,110 (-5.86%) | Filing History |
| 2024-01-25 11:11 am Unchanged | 2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN | JPMORGAN CHASE & CO JPM | 7,219,436 6.700% | 0 (Unchanged) | Filing History |
| 2024-01-25 11:10 am Purchase | 2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN | JPMORGAN CHASE & CO JPM | 7,219,436 6.700% | 1,118,392 (+18.33%) | Filing History |
| 2023-09-27 4:05 pm Sale | 2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 100 100.000% | -2,097,214 (-100.00%) | Filing History |
| 2023-08-18 5:16 pm Unchanged | 2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.300% | 0 (Unchanged) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN | Capital World Investors | 6,315,819 5.900% | 923,949 (+17.14%) | Filing History |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 11,096,984 10.362% | 287,238 (+2.66%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Regeneron Pharmaceuticals, Inc. REGN | The Vanguard Group | 8,722,448 8.150% | 563,933 (+6.91%) | Filing History |
| 2023-02-03 4:27 pm Sale | 2022-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN | BlackRock Inc. BLK | 9,166,817 8.600% | -444,054 (-4.62%) | Filing History |
| 2023-01-11 12:09 pm Purchase | 2022-12-30 | 13G | Regeneron Pharmaceuticals, Inc. REGN | JPMORGAN CHASE & CO JPM | 6,101,044 5.600% | 6,101,044 (New Position) | Filing History |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN | FMR LLC | 10,809,746 10.084% | 746,781 (+7.42%) | Filing History |
| 2022-02-11 4:07 pm Purchase | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | REGENERON PHARMACEUTICALS INC. REGN | 180,910 1.840% | 180,910 (New Position) | Filing History |
| 2022-02-11 4:06 pm Purchase | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | REGENERON PHARMACEUTICALS INC. REGN | 3,702,995 4.980% | 925,218 (+33.31%) | Filing History |
| 2022-02-11 4:05 pm Purchase | 2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | REGENERON PHARMACEUTICALS INC. REGN | 2,097,314 8.420% | 2,097,314 (New Position) | Filing History |